Poland· PL-100453403
Lecicarbon Junior
A kohlensäure-produzierende mittel product containing natrii hydrogenocarbonas + natrii dihydrogenophosphas, registered in Poland by athenstaedt GmbH & Co KG. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Kohlensäure-produzierende mittel is registered in 3 of 19 countries.
Countries holding a registration under ATC A06AX02 (kohlensäure-produzierende mittel), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Kohlensäure-produzierende mittel · ATC A06AX02
3 / 19 countries
- Finlandprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Natrii hydrogenocarbonas + Natrii dihydrogenophosphas
- Manufacturer
- athenstaedt GmbH & Co KG
- Country
- Poland (PL)
- ATC code
- A06AX02
- ATC class
- Kohlensäure-produzierende Mittel
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin04260017512859
- gtin04260017512866
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Kohlensäure-produzierende mittel in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyLecicarbon E Co2-LaxansAthenstaedt Gmbh & Co Kg
- SwitzerlandLecicarbon, Suppositorien für Erwachseneathenstaedt AG
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Lecicarbon E Co2-Laxans, Lecicarbon E Co2-Laxans Drei
- United Kingdom (Northern Ireland) · Carbalax
- Hungary · Lecicarbon Felnőtt, Lecicarbon Gyermek
- Luxembourg · Lecicarbon E Co2-Laxans Drei, Lecicarbon K Co2-Laxans Drei
- Slovenia · Lecicarbon Za Odrasle, Lecicarbon Za Otroke
- Slovakia · Lecicarbon Dospelí, Lecicarbon Pediatrickí Pacienti
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa3a7f0d-39b2-4f35-9e95-8c2754aa4f85 GET /v1/drugs/fa3a7f0d-39b2-4f35-9e95-8c2754aa4f85?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Czopki",
"source": "urpl",
"strength": "250 mg + 340 mg",
"packaging": "04260017512859 ¦ OTC ¦ 151740\n10 szt.\n04260017512866 ¦ OTC ¦ 151741\n50 szt.",
"substance": "Natrii hydrogenocarbonas 250 mg + Natrii dihydrogenophosphas 340 mg",
"common_name": "Natrii hydrogenocarbonas + Natrii dihydrogenophosphas",
"pl_product_id": "100453403",
"pozwolenie_nr": "28915",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about kohlensäure-produzierende mittel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.